Yüklüyor......
Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis
BACKGROUND AND OBJECTIVES: The principle defect in dense deposit disease and C3 glomerulonephritis is hyperactivity of the alternative complement pathway. Eculizumab, a monoclonal antibody that binds to C5 to prevent formation of the membrane attack complex, may prove beneficial. DESIGN, SETTING, PA...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Nephrology
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3338285/ https://ncbi.nlm.nih.gov/pubmed/22403278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.12901211 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|